"Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device." by Gregory Giugliano, MD

Article

Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device.

All Scholarly Works

Gregory Giugliano, MD, Baystate Health

Document Type

Article, Peer-reviewed

Publication Date

1-1-2005

Abstract

Distal balloon occlusion was approved as a means of embolic protection during saphenous vein graft intervention based on its ability to decrease major adverse clinical events (MACEs) by 42% in the 801-patient Saphenous Vein Graft Angioplasty Free of Embol

Publication ISSN

0195-9131

Citation Information

Am J Cardiol 2005 Jan 15;95(2):173-7.